Literature DB >> 14522566

Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias.

Jonathan R Emberson1, Peter H Whincup, Richard W Morris, Mary Walker.   

Abstract

AIMS: To estimate the combined contribution of serum total cholesterol, blood pressure and cigarette smoking to coronary heart disease (CHD) risk after adjustment for regression dilution bias. METHODS AND
RESULTS: Six thousand, five hundred and thirteen middle-aged British men without CHD were followed for major CHD events over 10 years. The population attributable risk fraction (PARF) was predicted for a range of risk factor thresholds before and after adjustment for regression dilution of serum total cholesterol and blood pressure. Defining 'low-risk' individuals as being in the bottom tenth of the population distributions of serum total cholesterol (<5.2 mmol/l) and diastolic blood pressure (<70 mmHg) and a non-cigarette smoker, the PARF was 75%, increasing to 86% after adjustment for regression dilution. Regardless of the threshold criteria chosen, the PARF was substantially greater than 65% before adjustment for regression dilution and greater than 75% after adjustment. Exclusion of ex-smokers and passive smokers from the low-risk group increased estimates further. Adjustment for other coronary risk factors had little effect on the results.
CONCLUSIONS: At least 80% of major CHD events in middle-aged men can be attributed to the three strongest risk factors. Population-wide control of these factors is crucial for effective CHD prevention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522566     DOI: 10.1016/s0195-668x(03)00471-8

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  21 in total

1.  Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey.

Authors:  Cesar de Oliveira; Richard Watt; Mark Hamer
Journal:  BMJ       Date:  2010-05-27

2.  Will generic hypertension guidelines reduce the proliferation of directives?

Authors:  Jan A Staessen; Eoin O'Brien
Journal:  Heart       Date:  2007-07       Impact factor: 5.994

Review 3.  Exercise for people with high cardiovascular risk.

Authors:  Pamela Seron; Fernando Lanas; Hector Pardo Hernandez; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2014-08-13

4.  Predicted 10-year risk of cardiovascular disease is influenced by the risk equation adopted: a cross-sectional analysis.

Authors:  Benjamin J Gray; Richard M Bracken; Daniel Turner; Kerry Morgan; Stephen D Mellalieu; Michael Thomas; Sally P Williams; Meurig Williams; Sam Rice; Jeffrey W Stephens
Journal:  Br J Gen Pract       Date:  2014-10       Impact factor: 5.386

5.  Influence of common genetic variation on blood lipid levels, cardiovascular risk, and coronary events in two British prospective cohort studies.

Authors:  Sonia Shah; Juan P Casas; Tom R Gaunt; Jackie Cooper; Fotios Drenos; Delilah Zabaneh; Daniel I Swerdlow; Tina Shah; Reecha Sofat; Jutta Palmen; Meena Kumari; Mika Kivimaki; Shah Ebrahim; George Davey Smith; Debbie A Lawlor; Philippa J Talmud; John Whittaker; Ian N M Day; Aroon D Hingorani; Steve E Humphries
Journal:  Eur Heart J       Date:  2012-09-13       Impact factor: 29.983

6.  Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000.

Authors:  Kathleen Bennett; Zubair Kabir; Belgin Unal; Emer Shelley; Julia Critchley; Ivan Perry; John Feely; Simon Capewell
Journal:  J Epidemiol Community Health       Date:  2006-04       Impact factor: 3.710

7.  Estimating the cardiovascular mortality burden attributable to the European Common Agricultural Policy on dietary saturated fats.

Authors:  Ffion Lloyd-Williams; Martin O'Flaherty; Modi Mwatsama; Christopher Birt; Robin Ireland; Simon Capewell
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408

Review 8.  Regression of vascular calcification in chronic kidney disease - feasible or fantasy? a review of the clinical evidence.

Authors:  Oscar Leonard; Jonas Spaak; David Goldsmith
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

Review 9.  Considerations for Measurement of Sodium Intake.

Authors:  Vanessa Almeida; Todd Seto; Jinan Banna
Journal:  Am J Lifestyle Med       Date:  2020-08-06

Review 10.  Familial Hypercholesterolaemia in the Era of Genetic Testing.

Authors:  D P Hughes; A Viljoen; A S Wierzbicki
Journal:  Curr Cardiol Rep       Date:  2016-05       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.